Trial intelligence / Profile preview

Lenalidomide, Bendamustine and Rituximab in Elderly Mantle Cell Lymphoma

NCT00963534Phase 2Completed

Sponsor
Skåne University Hospital
Start
Sep 2009
Primary completion
Aug 2017
Modality
Small Molecules
Countries
4
01

Overview

A Phase 2 trial of lenalidomide in mantle cell lymphoma (MCL), sponsored by Skåne University Hospital. Started Sep 2009; status: completed.

02

Drugs

lenalidomide
03

Conditions

mantle cell lymphoma (MCL)

Beyond the preview

Go deeper on NCT00963534.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00963534.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call